These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 6093521)

  • 1. Variability of ceftriaxone pharmacokinetics in hospitalized patients with severe infections.
    Joos B; Luethy R; Muehlen E; Siegenthaler W
    Am J Med; 1984 Oct; 77(4C):59-62. PubMed ID: 6093521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of ceftriaxone in subjects with renal insufficiency.
    Kowalsky SF; Echols RM; Parker MA
    Clin Pharm; 1985; 4(2):177-81. PubMed ID: 3987216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of ceftriaxone in patients with renal and liver insufficiency and correlations with a physiologic nonlinear protein binding model.
    Stoeckel K; Koup JR
    Am J Med; 1984 Oct; 77(4C):26-32. PubMed ID: 6093514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic profile of ceftriaxone in man.
    Patel IH; Kaplan SA
    Am J Med; 1984 Oct; 77(4C):17-25. PubMed ID: 6093513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of ceftriaxone after intravenous infusion and intramuscular injection.
    Scully BE; Fu KP; Neu HC
    Am J Med; 1984 Oct; 77(4C):112-6. PubMed ID: 6093511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Doses of antibiotic in patients with renal insufficiency.
    Ohkawa M; Kuroda K
    Clin Ther; 1981; 4 Suppl A():124-32. PubMed ID: 6275994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacokinetics of ceftriaxone in intensive care].
    Bouget J; Garré M; Reyman JM; Guedes Y; Cartier F
    Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):706-10. PubMed ID: 3054752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pharmacokinetics of cefotaxime and ceftriaxone in renal and hepatic dysfunction.
    Wise R; Wright N
    Infection; 1985; 13 Suppl 1():S145-50. PubMed ID: 4055047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-dose plasma and cerebrospinal fluid pharmacokinetics of ceftriaxone in infants and children.
    Reed MD; Rekate HL; Aronoff SC; Myers CM; Blumer JL
    Clin Pharm; 1983; 2(6):558-63. PubMed ID: 6317277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ceftriaxone therapy of meningitis and serious infections.
    Steele RW
    Am J Med; 1984 Oct; 77(4C):50-3. PubMed ID: 6093519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacokinetics of cefotaxime in patients with chronic renal impairment (author's transl)].
    Fillastre JP; Ings RM; Leroy A; Humbert G; Godin M
    Nouv Presse Med; 1981 Feb; 10(8):574-9. PubMed ID: 6259595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single daily dose treatment of severe refractory infections with ceftriaxone. Cost savings and possible parenteral outpatient treatment.
    Baumgartner JD; Glauser MP
    Arch Intern Med; 1983 Oct; 143(10):1868-73. PubMed ID: 6312914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Human pharmacology of ceftriaxone (author's transl)].
    Le Van Thoi J; Koumare B; Lhoste F; Soussy CJ; Duval J
    Pathol Biol (Paris); 1982 Jun; 30(6):345-7. PubMed ID: 6287386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ceftriaxone therapy for pediatric infections].
    Nagamatsu I; Miyanosita A; Abe K
    Jpn J Antibiot; 1984 Nov; 37(11):2003-11. PubMed ID: 6098695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of cefotaxime after a single intravenous dose in patients with impaired renal function.
    Moukhtar I; Nawishy S; Sabbour M
    Chemioterapia; 1987 Feb; 6(1):38-40. PubMed ID: 3829135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of ceftriaxone and cefazolin prophylaxis against infection in open heart surgery.
    Beam TR; Raab TA; Spooner JA; Balderman SC; Aldridge J; Bahyana JN
    Am J Surg; 1984 Oct; 148(4A):8-14. PubMed ID: 6091484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical and pharmacokinetic evaluation of ceftriaxone in children].
    Fujita K; Sakata H; Murono K; Yoshioka H; Maruyama S; Sanae N
    Jpn J Antibiot; 1984 Dec; 37(12):2271-82. PubMed ID: 6098720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ceftriaxone, a long-acting cephalosporin. Microbiological, kinetic and clinical study].
    Soranzo ML; Capra E; Angela GC; Eandi M; Salassa B; Lollini P; Musso E; Pizzo L; Spezia C; Di Nola F
    Minerva Med; 1983 Sep; 74(36):2093-102. PubMed ID: 6312379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacokinetics of cefotaxime and metabolites in uremic patients (author's transl)].
    Fillastre JP; Ings RM; Leroy A; Godin M; Humbert G
    Nephrologie; 1982; 3(1):12-8. PubMed ID: 6283411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The safety and pharmacokinetics of cefotaxime in the treatment of neonates.
    de Louvois J; Mulhall A; Hurley R
    Pediatr Pharmacol (New York); 1982; 2(4):275-84. PubMed ID: 6099886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.